L'Occitane International S.A. (0973.HK)
HKD 33.8
(0.3%)
HKD 33.8
(0.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.72 Billion EUR | 25.2% |
| 2022 | 1.37 Billion EUR | 17.42% |
| 2021 | 1.17 Billion EUR | 12.08% |
| 2020 | 1.04 Billion EUR | -9.41% |
| 2019 | 1.15 Billion EUR | 11.31% |
| 2018 | 1.03 Billion EUR | 8.08% |
| 2017 | 957.99 Million EUR | 2.56% |
| 2016 | 934.08 Million EUR | 4.53% |
| 2015 | 893.58 Million EUR | 12.06% |
| 2014 | 797.41 Million EUR | 10.52% |
| 2013 | 721.48 Million EUR | 3.57% |
| 2012 | 696.63 Million EUR | 15.49% |
| 2011 | 603.21 Million EUR | 19.48% |
| 2010 | 504.87 Million EUR | 29.47% |
| 2009 | 389.94 Million EUR | 10.74% |
| 2008 | 352.13 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q4 | 510.65 Million EUR | 0.0% |
| 2023 Q1 | 387.03 Million EUR | -11.72% |
| 2023 Q2 | 387.03 Million EUR | 0.0% |
| 2023 FY | 1.72 Billion EUR | 25.2% |
| 2023 Q3 | 510.65 Million EUR | 31.94% |
| 2022 Q3 | 438.44 Million EUR | 36.16% |
| 2022 Q2 | 322.01 Million EUR | 0.0% |
| 2022 FY | 1.37 Billion EUR | 17.42% |
| 2022 Q1 | 322.01 Million EUR | -4.88% |
| 2022 Q4 | 438.44 Million EUR | 0.0% |
| 2021 Q3 | 338.52 Million EUR | 41.73% |
| 2021 Q1 | 238.84 Million EUR | -18.55% |
| 2021 Q2 | 238.84 Million EUR | 0.0% |
| 2021 Q4 | 338.52 Million EUR | 0.0% |
| 2021 FY | 1.17 Billion EUR | 12.08% |
| 2020 FY | 1.04 Billion EUR | -9.41% |
| 2020 Q1 | 239.34 Million EUR | -21.99% |
| 2020 Q2 | 239.34 Million EUR | 0.0% |
| 2020 Q3 | 293.25 Million EUR | 22.52% |
| 2020 Q4 | 293.25 Million EUR | 0.0% |
| 2019 Q3 | 306.8 Million EUR | 12.2% |
| 2019 FY | 1.15 Billion EUR | 11.31% |
| 2019 Q4 | 306.8 Million EUR | 0.0% |
| 2019 Q2 | 273.44 Million EUR | 0.0% |
| 2019 Q1 | 273.44 Million EUR | -0.4% |
| 2018 FY | 1.03 Billion EUR | 8.08% |
| 2018 Q4 | 274.53 Million EUR | 0.0% |
| 2018 Q3 | 274.53 Million EUR | 12.88% |
| 2018 Q1 | 243.21 Million EUR | -6.11% |
| 2018 Q2 | 243.21 Million EUR | 0.0% |
| 2017 Q2 | 221.78 Million EUR | 0.0% |
| 2017 FY | 957.99 Million EUR | 2.56% |
| 2017 Q3 | 259.02 Million EUR | 16.79% |
| 2017 Q4 | 259.02 Million EUR | 0.0% |
| 2017 Q1 | 221.78 Million EUR | -11.15% |
| 2016 Q4 | 249.61 Million EUR | 0.0% |
| 2016 Q3 | 249.61 Million EUR | 15.08% |
| 2016 Q2 | 216.89 Million EUR | 0.0% |
| 2016 Q1 | 216.89 Million EUR | -8.9% |
| 2016 FY | 934.08 Million EUR | 4.53% |
| 2015 Q4 | 238.09 Million EUR | 0.0% |
| 2015 FY | 893.58 Million EUR | 12.06% |
| 2015 Q1 | 212.12 Million EUR | -3.62% |
| 2015 Q2 | 212.12 Million EUR | 0.0% |
| 2015 Q3 | 238.09 Million EUR | 12.24% |
| 2014 Q2 | 174.98 Million EUR | 0.0% |
| 2014 FY | 797.41 Million EUR | 10.52% |
| 2014 Q4 | 220.09 Million EUR | 0.0% |
| 2014 Q1 | 174.98 Million EUR | -9.2% |
| 2014 Q3 | 220.09 Million EUR | 25.78% |
| 2013 FY | 721.48 Million EUR | 3.57% |
| 2013 Q1 | 174.71 Million EUR | -5.15% |
| 2013 Q2 | 174.71 Million EUR | 0.0% |
| 2013 Q3 | 192.72 Million EUR | 10.31% |
| 2013 Q4 | 192.72 Million EUR | 0.0% |
| 2012 Q4 | 184.2 Million EUR | 0.0% |
| 2012 Q1 | 165.25 Million EUR | 9.59% |
| 2012 Q2 | 165.25 Million EUR | 0.0% |
| 2012 Q3 | 184.2 Million EUR | 11.47% |
| 2012 FY | 696.63 Million EUR | 15.49% |
| 2011 Q4 | 150.8 Million EUR | 0.0% |
| 2011 FY | 603.21 Million EUR | 19.48% |
| 2011 Q1 | 126.21 Million EUR | 0.0% |
| 2011 Q2 | 126.21 Million EUR | 0.0% |
| 2011 Q3 | 150.8 Million EUR | 19.48% |
| 2010 FY | 504.87 Million EUR | 29.47% |
| 2010 Q4 | 126.21 Million EUR | 0.0% |
| 2010 Q3 | 126.21 Million EUR | 29.47% |
| 2010 Q2 | 97.48 Million EUR | 0.0% |
| 2010 Q1 | 97.48 Million EUR | 0.0% |
| 2009 Q4 | 97.48 Million EUR | 0.0% |
| 2009 Q2 | 88.03 Million EUR | 0.0% |
| 2009 Q1 | 88.03 Million EUR | 0.0% |
| 2009 FY | 389.94 Million EUR | 10.74% |
| 2009 Q3 | 97.48 Million EUR | 10.74% |
| 2008 FY | 352.13 Million EUR | 0.0% |
| 2008 Q3 | 88.03 Million EUR | 0.0% |
| 2008 Q4 | 88.03 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 204.08 Million HKD | -742.91% |
| Innovative Pharmaceutical Biotech Limited | 14.27 Million HKD | -11951.534% |
| China Overseas Nuoxin International Holdings Limited | 38.32 Million HKD | -4388.314% |
| Prosperous Future Holdings Limited | 118.15 Million HKD | -1355.964% |
| Huasheng International Holding Limited | 153.46 Million HKD | -1020.945% |
| Fourace Industries Group Holdings Limited | 57.65 Million HKD | -2883.62% |
| Evergreen Products Group Limited | 152.17 Million HKD | -1030.462% |
| EC Healthcare | 597.44 Million HKD | -187.931% |
| Ming Fai International Holdings Limited | 357.68 Million HKD | -380.941% |
| Blue Moon Group Holdings Limited | 4.4 Billion HKD | 60.992% |
| SuperRobotics Holdings Limited | 15.16 Million HKD | -11246.455% |
| Takbo Group Holdings Limited | 65.71 Million HKD | -2517.602% |
| Hyfusin Group Holdings Limited | 196.91 Million HKD | -773.615% |